Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010.

Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010.

Isoniazid mono-resistance (IMR) is the most common form of mono-resistance; its world prevalence is estimated to range between 0.0 to 9.5% globally. There is no consensus on how these patients should be treated.To describe the impact of IMR tuberculosis (TB) on treatment outcome and survival among p...

Full description

Bibliographic Details
Main Authors: Renata Báez-Saldaña, Guadalupe Delgado-Sánchez, Lourdes García-García, Luis Pablo Cruz-Hervert, Marlene Montesinos-Castillo, Leticia Ferreyra-Reyes, Miriam Bobadilla-Del-Valle, Sergio Canizales-Quintero, Elizabeth Ferreira-Guerrero, Norma Téllez-Vázquez, Rogelio Montero-Campos, Mercedes Yanes-Lane, Norma Mongua-Rodriguez, Rosa Areli Martínez-Gamboa, José Sifuentes-Osornio, Alfredo Ponce-de-León
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5193431?pdf=render

Internet

http://europepmc.org/articles/PMC5193431?pdf=render

Similar Items